BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 8, 2020
View Archived Issues
SH-229: phase II data in combination with daclatasvir in Chinese patients with chronic HCV
Read More
Incyte initiates phase I study of INCB-099280 in solid tumors
Read More
Development of BI-1467335 discontinued for diabetic retinopathy
Read More
Phase III study evaluates NA-831 plus OPV as prevention and treatment of early onset of COVID-19
Read More
Dracen Pharmaceuticals begins first-in-human study of DRP-104
Read More
BeiGene starts phase I study of SARS-CoV-2 neutralizing antibody BGB-DXP-593
Read More
New candidate breast cancer risk gene identified
Read More
JNK as a novel therapeutic target in cholestatic liver diseases
Read More
CRISPR immune suppression strengthens CRISPR gene therapy
Read More
mTOR-targeting metabolite discovered
Read More
AKG for A-OK aging
Read More
GYS2 identified as potential new prognostic biomarker in HCC
Read More
QKI-7 targeting restores endothelial cell function and improves vascular complications in diabetes
Read More
New Nav1.8 channel blockers patented by Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical
Read More
Adlai Nortye describes new PD-1/PD-L1 interaction inhibitors
Read More
Shenzhen Targetrx Biotechnology discovers RET inhibitors
Read More
An integrated pipeline for rapid discovery and validation of MAbs against viral pathogens
Read More
New PCSK9 inhibitors presented by the Wisconsin Alumni Research Foundation
Read More
Enterin identifies new PTP-1B inhibitors
Read More
Amplia receives ethics committee clearance for phase I trial of FAK inhibitor AMP-945
Read More
Inhibitory decoy gene created to inhibit Galpha-q for uveal melanoma treatment
Read More
Valneva advances chikungunya vaccine candidate VLA-1553 into phase III
Read More